ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,029Medicare Part D Prescriptions Filled, Including Refills

Rank: 36 out of 223

$576K Total Retail Price of All Prescriptions

Rank: 45 out of 223

504 Patients Receiving at Least One Drug in Part D
82%Patients 65 Years and Older
27% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Utah
Lower avg

Schedule Two
Controlled Substances

7% of this provider’s 504 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

14% of this provider’s 504 patients filled at least one prescription for a schedule three drug, compared to an average of 11%.

Risky Drugs to Seniors

2% of this provider’s 7,735 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

21% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$57 was the average price of a prescription from this provider, compared to $62 among peers.

Prescriptions per Patient

20 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Utah
OMEPRAZOLE 546 431 1 3
SIMVASTATIN 456 368 2 1
LEVOTHYROXINE SODIUM 379 331 3 2
LISINOPRIL 367 272 4 4
FUROSEMIDE 299 255 5 9
HYDROCODONE-ACETAMINOPHEN 231 165 S3 6 5
CARVEDILOL 225 207 7 23
AMLODIPINE BESYLATE 219 186 8 6
ALENDRONATE SODIUM 219 186 8 19
HYDROCHLOROTHIAZIDE 219 172 8 13
ZOLPIDEM TARTRATE 203 163 11 8
POTASSIUM CHLORIDE 189 164 12 12
CITALOPRAM HBR 181 125 13 16
PRAVASTATIN SODIUM 166 110 14 15
LOSARTAN POTASSIUM 157 142 15 14
METFORMIN HCL 153 113 16 7
ATORVASTATIN CALCIUM 148 127 17 17
WARFARIN SODIUM 140 133 18 11
GABAPENTIN 136 110 19 10
METOPROLOL SUCCINATE 134 116 20 20
FLUTICASONE PROPIONATE 106 77 21 27
TRAMADOL HCL 100 77 22 18
CRESTOR 99 73 23 37
GLIMEPIRIDE 89 53 24 30
CYMBALTA 79 36 25 40
FINASTERIDE 79 78 25 58
METOPROLOL TARTRATE 78 61 27 25
SYNTHROID 77 64 28 35
SERTRALINE HCL 77 61 28 21
TRAZODONE HCL 73 50 30 22
TAMSULOSIN HCL 67 65 31 26
ADVAIR DISKUS 64 49 32 47
CIPROFLOXACIN HCL 64 57 32 53
DIOVAN 60 58 34 54
FENOFIBRATE 56 42 35 38
LANTUS 56 20 35 34
PANTOPRAZOLE SODIUM 56 39 35 45
LISINOPRIL-HYDROCHLOROTHIAZIDE 55 53 38 29
OXYBUTYNIN CHLORIDE ER 54 54 39 109
SPIRONOLACTONE 53 39 40 55
ATENOLOL 51 48 41 32
ESCITALOPRAM OXALATE 51 37 41 104
ACETAMINOPHEN-CODEINE 50 29 S3 43 165
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on June 26, 2009.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.